Introduction Peptide drug formulation challenges encompass the complex chemical and physical degradation risks that biological drugs may encounter during freeze-drying, […]
Introduction Global contract development and manufacturing organization (CDMO) capacity is under severe pressure because the unprecedented multi-ton demand for semaglutide
Introduction Developing therapeutic peptides within a regulated environment requires selecting a synthetic strategy that effectively balances chemical scalability with stringent
Introduction: PLA nanoparticle formulation for targeted oncology delivery is one of the more demanding areas of parenteral drug development, because
Case Study: PLA Nanoparticle Formulation for Targeted Solid Tumour Oncology Delivery Read More »
Introduction: Nitrosamine Root Cause Investigation for Sartan APIs has become a defining requirement across pharmaceutical manufacturing following the global recalls
Introduction: ADME bioanalytical testing services are the analytical foundation that tells a drug developer whether a molecule behaves the way
ADME Bioanalytical Testing Services: What Drug Developers Need from a CRO Read More »
Introduction: Choosing the right CRO for Injectable Drug Development is one of the most important strategic decisions pharmaceutical and biotechnology
Selecting the Right CRO for Injectable Drug Development Read More »
Introduction: Developing a biosimilar monoclonal antibody involves far more than demonstrating analytical similarity with the reference product. One of the
Introduction Sponsors of generic drugs can improve their time-to-market and increase the likelihood of regulatory approval by utilizing comprehensive CDMO
Introduction This comprehensive research report examines the advanced scientific, aseptic manufacturing, and regulatory strategies necessary for the successful development and
